SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
30-Jun-21 6:06 PM View: | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Conversion Duplicate | 6,642,300 | -- | -- | 100% 0 to 6.64M | |
30-Jun-21 6:06 PM View: | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Purchase Duplicate | 1,050,000 | $19.00 | $19,950,000.00 | 16% 6.64M to 7.69M | |
30-Jun-21 9:31 PM View: | Neuehealth, Inc. (NEUE) | 28-Jun-21 | Conversion Duplicate | 133,640,000 | -- | -- | 285% 46.86M to 180.5M | |
30-Jun-21 9:31 PM View: | Neuehealth, Inc. (NEUE) | 28-Jun-21 | Market Purchase | 1,944,440 | $18.00 | $35,000,000.00 | 1% 180.5M to 182.44M | |
10-Jun-21 4:41 PM View: | Desktop Metal, Inc. (DM) | 08-Jun-21 | Acquisition (other) | 137,285 | -- | -- | < 1% 28.26M to 28.4M | |
10-Jun-21 4:41 PM View: | Desktop Metal, Inc. (DM) | 08-Jun-21 | Disposition (other) Duplicate | 9,135,000 | -- | -- | (32%) 28.4M to 19.27M | |
26-May-21 4:38 PM View: | Eargo, Inc. (EAR) | 24-May-21 | Acquisition (other) | 30,508 | -- | -- | < 1% 6.52M to 6.55M | |
26-May-21 4:38 PM View: | Eargo, Inc. (EAR) | 24-May-21 | Disposition (other) Duplicate | 2,030,000 | -- | -- | (31%) 6.55M to 4.52M | |
18-Mar-21 5:16 PM View: | Marker Therapeutics, Inc. (MRKR) | 16-Mar-21 | Market Purchase Duplicate | 5,714,280 | $1.75 | $10,000,000.00 | 114% 5.0M to 10.71M | (100%) |
07-Dec-20 5:12 PM View: | Regulus Therapeutics Inc. (RGLS) | 04-Dec-20 | Private Purchase Duplicate | 4,398,600 | $0.62 | $2,735,930.00 | 214% 2.05M to 6.45M | |
22-Oct-20 7:53 PM View: | Eargo, Inc. (EAR) | 20-Oct-20 | Conversion Duplicate | 6,208,910 | -- | -- | 100% 0 to 6.21M | |
22-Oct-20 7:53 PM View: | Eargo, Inc. (EAR) | 20-Oct-20 | Purchase Duplicate | 311,111 | $18.00 | $5,600,000.00 | 5% 6.21M to 6.52M | |
22-Sep-20 5:45 PM View: | Metacrine, Inc. (MTCR) | 18-Sep-20 | Conversion Duplicate | 2,291,300 | -- | -- | 100% 0 to 2.29M | |
22-Sep-20 5:45 PM View: | Metacrine, Inc. (MTCR) | 18-Sep-20 | Purchase Duplicate | 769,230 | $13.00 | $9,999,990.00 | 34% 2.29M to 3.06M | |
28-Jul-20 6:29 PM View: | Inozyme Pharma, Inc. (INZY) | 28-Jul-20 | Conversion Duplicate | 2,187,690 | -- | -- | 100% 0 to 2.19M | |
28-Jul-20 6:29 PM View: | Inozyme Pharma, Inc. (INZY) | 28-Jul-20 | Purchase Duplicate | 250,000 | $16.00 | $4,000,000.00 | 11% 2.19M to 2.44M | |
28-Jul-20 5:24 PM View: | Genocea Biosciences, Inc. (GNCA) | 24-Jul-20 | Private Purchase Duplicate | 3,151,260 | $2.25 | $7,090,340.00 | 44% 7.23M to 10.38M | |
16-Jul-20 5:00 PM View: | Nkarta, Inc. (NKTX) | 14-Jul-20 | Conversion Duplicate | 2,235,450 | -- | -- | 100% 0 to 2.24M | |
16-Jul-20 5:00 PM View: | Nkarta, Inc. (NKTX) | 14-Jul-20 | Purchase Duplicate | 666,666 | $18.00 | $12,000,000.00 | 30% 2.24M to 2.9M | |
01-Jul-20 5:36 PM View: | Akouos, Inc. (AKUS) | 30-Jun-20 | Conversion Duplicate | 3,705,970 | -- | -- | 100% 0 to 3.71M | |
01-Jul-20 5:36 PM View: | Akouos, Inc. (AKUS) | 30-Jun-20 | Purchase Duplicate | 588,235 | $17.00 | $10,000,000.00 | 16% 3.71M to 4.29M | |
22-Jun-20 5:29 PM View: | AVEO Pharmaceuticals, Inc. (AVEO) | 19-Jun-20 | Market Purchase Duplicate | 1,428,570 | $5.25 | $7,500,000.00 | 57% 2.52M to 3.95M | 9% |
13-Apr-20 9:00 PM View: | Trevi Therapeutics, Inc. (TRVI) | 03-Apr-20 | Market Sale Duplicate | 564 | $2.66 | $1,500.24 | (< 1%) 5.94M to 5.94M | 54% |
13-Apr-20 9:00 PM View: | Trevi Therapeutics, Inc. (TRVI) | 03-Apr-20 | Exercise (in-the money or at-the-money) Duplicate | 1,500,000 | $0.00 | $1,500.00 | 34% 4.44M to 5.94M | |
09-Dec-19 5:01 PM View: | Ardelyx, Inc. (ARDX) | 09-Dec-19 | Grant Duplicate | 400,000 | $6.25 | $2,500,000.00 | 6% 6.16M to 6.56M | 13% |
24-Jul-19 4:55 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 22-Jul-19 | Conversion Duplicate | 3,736,240 | -- | -- | 100% 0 to 3.74M | |
24-Jul-19 4:55 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 22-Jul-19 | Purchase Duplicate | 450,000 | $15.00 | $6,750,000.00 | 12% 3.74M to 4.19M | |
25-Jun-19 4:51 PM View: | Genocea Biosciences, Inc. (GNCA) | 24-Jun-19 | Market Purchase Duplicate | 2,857,140 | $3.50 | $10,000,000.00 | 65% 4.37M to 7.23M | (24%) |
13-May-19 5:13 PM View: | Trevi Therapeutics, Inc. (TRVI) | 09-May-19 | Conversion Duplicate | 1,938,560 | -- | -- | 100% 0 to 1.94M | |
13-May-19 5:13 PM View: | Trevi Therapeutics, Inc. (TRVI) | 09-May-19 | Purchase Duplicate | 2,500,000 | $10.00 | $25,000,000.00 | 129% 1.94M to 4.44M | |
09-May-19 6:06 PM View: | Regulus Therapeutics Inc. (RGLS) | 07-May-19 | Private Purchase Duplicate | 1,136,700 | $1.08 | $1,227,640.00 | 124% 915.75K to 2.05M | |
08-Apr-19 5:20 PM View: | AVEO Pharmaceuticals, Inc. (AVEO) | 08-Apr-19 | Market Purchase Duplicate | 4,347,830 | $1.14 | $4,956,520.00 | 21% 20.9M to 25.24M | (49%) |
19-Feb-19 5:03 PM View: | Genocea Biosciences, Inc. (GNCA) | 14-Feb-19 | Private Purchase Duplicate | 9,948,270 | $0.47 | $4,688,620.00 | 40% 25.0M to 34.95M | |
21-Dec-18 9:18 PM View: | AVEO Pharmaceuticals, Inc. (AVEO) | 21-Dec-18 | Market Purchase Duplicate | 300,000 | $1.49 | $448,380.00 | 1% 20.6M to 20.9M | (62%) |
21-Dec-18 9:18 PM View: | AVEO Pharmaceuticals, Inc. (AVEO) | 20-Dec-18 | Market Purchase Duplicate | 200,000 | $1.63 | $326,060.00 | < 1% 20.4M to 20.6M | (65%) |
12-Dec-18 4:42 PM View: | AVEO Pharmaceuticals, Inc. (AVEO) | 11-Dec-18 | Market Purchase Duplicate | 61,200 | $1.98 | $121,084.00 | < 1% 20.33M to 20.4M | (71%) |
10-Dec-18 5:21 PM View: | AVEO Pharmaceuticals, Inc. (AVEO) | 10-Dec-18 | Market Purchase Duplicate | 26,000 | $1.98 | $51,576.20 | < 1% 20.31M to 20.33M | (71%) |
10-Dec-18 5:21 PM View: | AVEO Pharmaceuticals, Inc. (AVEO) | 07-Dec-18 | Market Purchase Duplicate | 117,100 | $1.98 | $232,362.00 | < 1% 20.19M to 20.31M | (71%) |
10-Dec-18 5:21 PM View: | AVEO Pharmaceuticals, Inc. (AVEO) | 06-Dec-18 | Market Purchase Duplicate | 27,300 | $1.99 | $54,414.40 | < 1% 20.16M to 20.19M | (71%) |
30-Nov-18 5:12 PM View: | AVEO Pharmaceuticals, Inc. (AVEO) | 30-Nov-18 | Market Purchase Duplicate | 71,900 | $1.98 | $142,067.00 | < 1% 20.09M to 20.16M | (71%) |
30-Nov-18 5:12 PM View: | AVEO Pharmaceuticals, Inc. (AVEO) | 28-Nov-18 | Market Purchase Duplicate | 24,500 | $1.99 | $48,823.60 | < 1% 20.07M to 20.09M | (71%) |
21-Nov-18 4:43 PM View: | AVEO Pharmaceuticals, Inc. (AVEO) | 20-Nov-18 | Market Purchase Duplicate | 170,000 | $1.98 | $336,107.00 | < 1% 19.9M to 20.07M | (71%) |
19-Nov-18 7:42 PM View: | AVEO Pharmaceuticals, Inc. (AVEO) | 19-Nov-18 | Market Purchase Duplicate | 510,000 | $1.88 | $956,658.00 | 3% 19.39M to 19.9M | (69%) |
19-Nov-18 7:42 PM View: | AVEO Pharmaceuticals, Inc. (AVEO) | 16-Nov-18 | Market Purchase Duplicate | 350,000 | $1.86 | $649,355.00 | 2% 19.04M to 19.39M | (69%) |
19-Nov-18 7:42 PM View: | AVEO Pharmaceuticals, Inc. (AVEO) | 15-Nov-18 | Market Purchase Duplicate | 340,000 | $1.86 | $631,958.00 | 2% 18.7M to 19.04M | (69%) |
22-Aug-18 4:44 PM View: | AVEO Pharmaceuticals, Inc. (AVEO) | 21-Aug-18 | Market Purchase Duplicate | 663,716 | $2.26 | $1,500,000.00 | 4% 18.03M to 18.7M | (75%) |
20-Jul-18 4:43 PM View: | AVEO Pharmaceuticals, Inc. (AVEO) | 19-Jul-18 | Market Purchase Duplicate | 50,600 | $2.00 | $101,165.00 | < 1% 17.98M to 18.03M | (71%) |
20-Jul-18 4:43 PM View: | AVEO Pharmaceuticals, Inc. (AVEO) | 18-Jul-18 | Market Purchase Duplicate | 200,000 | $1.95 | $390,580.00 | 1% 17.78M to 17.98M | (71%) |
28-Jun-18 7:19 PM View: | AVEO Pharmaceuticals, Inc. (AVEO) | 28-Jun-18 | Market Purchase Duplicate | 187,130 | $2.10 | $392,692.00 | 1% 17.6M to 17.78M | (73%) |
28-Jun-18 7:19 PM View: | AVEO Pharmaceuticals, Inc. (AVEO) | 27-Jun-18 | Market Purchase Duplicate | 5,295 | $2.15 | $11,384.30 | < 1% 17.59M to 17.6M | (73%) |